Affiliation:
1. Division of Pediatric Infectious Diseases, Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey
2. Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey
3. Department of Medical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Abstract
Objective:
To describe clinical and epidemiological characteristics, antimicrobial susceptibility and mortality-associated factors of healthcare-associated infections (HCAIs) caused by Staphylococcus
(S.) aureus in children.
Methods:
We conducted a retrospective, single-centre study of pediatric HCAIs caused by S. aureus from a tertiary care hospital in Turkey between February 2014 and December 2019. The clinical and epidemiological characteristics and antimicrobial susceptibility of the methicillin-susceptible and methicillin-resistant S. aureus (MSSA and MRSA) isolates was evaluated.
Results:
A total of 310 pediatric patients were examined. Overall, 225 (72.6%) isolates were MSSA and 85 (27.4%) were MRSA. All S. aureus isolates were susceptible to teicoplanin, vancomycin, linezolid, tigecycline, mupirocin, and daptomycin. Penicillin resistance rates were high (89.0%), while fosfomycin, gentamicin, and clindamycin resistance rates were low (1.3%, 1.0%, and 2.3%, respectively). Except susceptibility to fosfomycin, which was significantly lower in 2014 compared to 2018 and 2019, no significant difference was found in the antimicrobial susceptibility of S. aureus isolates between the years. Baseline characteristics and mortality rate were similar comparing MRSA and MSSA causing HCAIs. The mortality rate of HCAIs caused by S. aureus was 6.5% (20 patients). Malignancy was an independent risk factor associated with mortality in the multivariate analysis (OR 5.446, 95% CI 1.573-18.849).
Conclusions:
Our findings demonstrate that MSSA remained the most causative agent of HCAIs caused by S. aureus. The mortality rate was 6.5%, the antibiotic resistance rate was quite high for penicillin and diagnosis of malignancy was the main risk factor for increasing mortality in children. These findings could help improve the management of HCAIs caused by S. aureus in children.
Reference25 articles.
1. Staphylococcus aureus: A pathogen with still unresolved issues;Rasigade;Infect Genet Evol,2014
2. Staphylococcus aureus ınfections: Epidemiology, pathophysiology, clinical manifestations, and management;Tong;Clin Microbiol Rev,2015
3. MRSA colonization and risk of ınfection in the neonatal and pediatric ICU: A meta-analysis;Zervou;Pediatrics,2014
4. Burdens of invasive methicillin-susceptible and methicillin-resistant Staphylococcus aureus disease, Minnesota, USA;Koeck;Emerg Infect Dis,2019
5. Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia;Jokinen;Infect Dis,2018